Skip to content

Status
Not yet recruiting
Phases
Phase 2
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2014-000078-21-FR
Enrollment
90
Registered
2015-06-26
Start date
2015-04-08
Completion date
Unknown
Last updated
2019-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Product Name: Cellules souches mésenchymateuses autologues Pharmaceutical Form: Solution for injection in pre-filled syringe Pharmaceutical form of the placebo: Solutio

Sponsors

CHU Toulouse
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 90 F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Primary end point(s): ;Main Objective: ;Secondary Objective:

Countries

France

Contacts

Public ContactDelphine Aravit

CHU Toulouse

aravit.d@chu-toulouse.fr330561778597

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026